(Q54722374)

3 June 2018

reason for preferred rank

title

Clinical evaluation of l-asparaginase.Introduction (English)

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

Clinical evaluation of L-asparaginase. Introduction (English)

1 reference

PubMed ID

4905151

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4905151

17 March 2023

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

1

Burchenal JH

1 reference

3 June 2018

author name string

D. A. Karnofsky

2

1 reference

PubMed ID

4905151

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4905151

17 March 2023

language of work or name

English

0 references

publication date

1 February 1970

1 reference

3 June 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

1 reference

3 June 2018

volume

25

1 reference

3 June 2018

page(s)

241-243

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase

cites work

2

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

17 March 2023

3

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance

17 March 2023

4

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors

17 March 2023

9

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Response of Intracerebral Gardner Lymphoma to Guinea Pig L-Asparaginase and Escherichia coli L-Asparaginase

17 March 2023

13

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Toxic and antineoplastic effects of L-asparaginase. Study of mice with lymphoma and normal monkeys and report on a child with leukemia.

17 March 2023

14

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Studies of the culture of leukemic cells in vitro

17 March 2023

15

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine

17 March 2023

17

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

18

21

532

Haley

1961

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum

17 March 2023

21

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI

17 March 2023

22

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine

17 March 2023

23

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

24

27

2619

Oettgen

1967

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Toxicity of E. coli L-asparaginase in man

17 March 2023

25

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Leukæmia-inhibiting Properties and L-Asparaginase Activity of Sera from Certain South American Rodents

17 March 2023

26

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

Treatment of lymphosarcoma in the dog with L-asparaginase

17 March 2023

27

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

L-asparaginase activity in plasma and other biological fluids

17 March 2023

28

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

17 March 2023

29

1 reference

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197002)25:2%3C241::AID-CNCR2820250202%3E3.0.CO;2-6

17 March 2023

Identifiers

10.1002/1097-0142(197002)25:2<241::AID-CNCR2820250202>3.0.CO;2-6

1 reference

3 June 2018

PubMed ID

4905151

1 reference

3 June 2018